Zemley Pharma Novotech ( Ningbo) Co.

What Zemley Pharma Novotech ( Ningbo) Co. does

Zemley Pharma Novotech (Ningbo) Co., Ltd. is the overseas marketing and export arm of Ningbo Zhengli Pharmaceutical Packaging Co., Ltd., a Chinese pharmaceutical glass packaging manufacturer founded in 1991 and headquartered in Ningbo, Zhejiang Province. The company designs and manufactures Type I glass primary packaging — including tubular glass vials (2R–50R, clear and amber), glass prefilled syringes (0.5ml–3ml), glass cartridges (1.8ml and 3ml), and ampoules (1ml–30ml) — for injectable drugs, biologics, vaccines, blood products, insulin pen systems, dental drug delivery, cosmetic injectables, and ophthalmic preparations. Its flagship SteriPak™ sterile series delivers ready-to-use (R2U) prefilled syringes, vials, and cartridges that are washed, siliconized, ETO-sterilized, and nest-packaged on fully automated production lines with 100% inline camera inspection in cGMP-qualified facilities.

The company monetizes primarily through direct sale of these glass containers to pharmaceutical and biotech manufacturers, with a sales-led, event-driven go-to-market reinforced by major trade-show presence (CPHI Shanghai) and dedicated overseas sales roles. Reported annual production capacity is 2 billion tubular vials, 100 million glass prefilled syringes, 100 million glass cartridges, and 600 million ampoules; domestic market share is reported at 80% in biological vaccine packaging and 50% in high-end special drugs. Zemley is the named major packaging supplier for Sinopharm and SinoVax COVID-19 vaccines (Sinopharm's vaccine was listed by WHO for emergency use in May 2021 and shipped for COVAX), and operates within an explicit Tier-1 supplier ecosystem that includes SCHOTT (Type I glass tubing), West Pharmaceutical Services, Datwyler, Dow (silicone chemistry), Handle, and HRS. Certifications include ISO13485, ISO15378, and ISO9001, plus a filed Drug Master File, with vial compliance to Pharm. Eur., USP, JP, and FEUM standards.

Ownership and capital structure are entirely private and family-controlled via Zhengli Investment; no venture capital, private equity, or public-market financing is disclosed. Pricing is not published on the website and customers are directed to request quotes, consistent with a custom-specification, contract-based enterprise sales model rather than standardized catalog distribution. Zemley Pharma Novotech (Ningbo) Co. itself serves as the international-facing brand, with the Jiangbei, Ningbo facility operated by Ningbo Zhengli acting as the manufacturing base.

Name

Zemley Pharma Novotech ( Ningbo) Co.

Legal name

Zemley Pharma Novotech (Ningbo) Co., Ltd.

Website

https://zemleypharma.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Zemley Pharma Novotech (Ningbo) Co. is the overseas marketing arm of Ningbo Zhengli Pharmaceutical Packaging, a Chinese manufacturer of Type I glass vials, prefilled syringes, cartridges, and ampoules — including its SteriPak™ ready-to-use sterile series — serving pharmaceutical, biotech, vaccine, and drug-delivery customers globally.

Ownership category

akta.pro rank

Product category

Pharmaceutical Glass Packaging

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Glass Containers (3221)

akta.pro primary industry

Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB)

akta.pro secondary industries

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)

Keywords

• Pharmaceutical glass packaging
• Sterile injectable containers
• Glass vials and syringes
• Primary packaging solutions
• Vaccine packaging containers

Headquarters

HQ city

Ningbo

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Infrastructure, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Pharmaceutical Glass Packaging Products: Sale of glass containers including tubular vials, glass prefilled syringes, glass cartridges, and ampoules to pharmaceutical, biotech, vaccine, and cosmetic companies. Products are manufactured to specification (customized solutions available) and sold directly to pharmaceutical manufacturers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Zemley Pharma Novotech manufactures pharmaceutical-grade glass primary packaging containers including tubular vials, prefilled syringes (PFS), cartridges, and ampoules for injectable drugs, vaccines, biologics, blood products, and cosmetics. The flagship SteriPak™ sterile series provides ready-to-use (R2U) ETO-sterilized containers in nest format, eliminating the need for in-house sterilization by pharmaceutical customers. Products comply with Pharm. Eur., USP, JP, and FEUM standards and are produced at scale for vaccine and biotech manufacturers including Sinopharm and SinoVax.

Product overview

Zemley Pharma Novotech (Ningbo) Co. is a pharmaceutical packaging manufacturer specializing in glass containers, primarily serving the anti-tumor, biotech, vaccine, blood products, contact lenses, and cosmetic industries. The company operates as the overseas marketing brand of Ningbo Zhengli Pharmaceutical Packaging (founded in 1991) and offers a comprehensive portfolio of glass packaging products including tubular vials (with variants like siliconized and customized vials), prefilled syringes, cartridges, and ampoules. The flagship SteriPak™ sterile series provides ready-to-use, ETO-sterilized packaging in nest format for clinical trials and industrialization, while standard products are offered for general pharmaceutical applications. Annual production capacity includes 2 billion tubular vials, 100 million glass pre-fillable syringes, 100 million glass cartridges, and 600 million ampoules. The company is a major packaging supplier for COVID-19 vaccines for Sinopharm and SinoVax.

Differentiator

Problem solved

Functional benefit

Brands

• SteriPak™: Sterile series packaging products including SteriPak™ prefilled syringes, SteriPak™ vials, and SteriPak™ cartridges - ready-to-use ETO sterilized packaging solutions in nest format for pharmaceutical companies.

Products and services

• Glass Tubular Vials

Quantifiable outcome

• 80% domestic market share in biological vaccine segment
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and minor.

• SCHOTTcoreTechnology or IntegrationSCHOTT is a key glass tubing supplier for Zemley, providing pharmaceutical Type I glass tubing used in Zemley's vials, prefilled syringes, and cartridges. SCHOTT is a globally leading supplier of pharmaceutical primary glass packaging materials.
• SinopharmcoreOthersSinopharm (China National Pharmaceutical Group) is a major customer for Zemley's COVID-19 vaccine packaging. Zemley serves as the major packaging supplier for Sinopharm's COVID-19 vaccines (including the vaccine with 86% efficacy as confirmed by UAE). Sinopharm finished first batch of COVID-19 vaccine for COVAX in June 2021 using Zemley glass vials.
• SinoVaxcoreOthersSinoVax is listed as a major COVID-19 vaccine customer alongside Sinopharm, for whom Zemley serves as the major packaging supplier.
• LivzonminorOthersLivzon (Livzon Pharmaceutical Group) is listed as a partner, likely a pharmaceutical customer for Zemley's glass packaging products.
• WalvaxminorOthersWalvax (Walvax Biotechnology Co., Ltd.) is listed as a partner. Walvax is a Chinese biotech company developing and manufacturing vaccines, making it a potential customer for Zemley's pharmaceutical packaging.
• SinovacminorOthersSinovac Biotech is listed as a partner. Sinovac is a leading Chinese vaccine developer and manufacturer, and Zemley likely supplies packaging for Sinovac's COVID-19 vaccines (such as CoronaVac).

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Gerresheimer: Gerresheimer is a leading global manufacturer of primary packaging made of glass and plastic for pharma and cosmetics, including vials, ampoules, syringes and cartridges. Directly comparable to Zemley across tubular vials, ampoules, and PFS for biologics and vaccines.
• SGD Pharma: SGD Pharma (Saint-Gobain) specializes in pharmaceutical glass packaging including tubular vials, molded vials, ampoules and syringes. Direct rival in pharmaceutical glass primary containers with comparable product breadth and regulatory positioning.
• DWK Life Sciences: DWK Life Sciences (formerly Wheaton) produces specialty glass packaging including pharmaceutical vials, ampoules, and drug delivery components for life sciences. Comparable to Zemley in tubular and molded glass primary packaging for injectable drugs.
• Stevanato Group: Stevanato Group produces pharmaceutical glass containers (vials, syringes, cartridges) and integrated drug containment solutions for injectables. It is a direct competitor in Type I glass vials and ready-to-use PFS, with overlapping customer base of biologics and vaccine manufacturers.
• SCHOTT Pharma: SCHOTT Pharma is the global leader in pharmaceutical Type I glass tubing and primary packaging (vials, syringes, cartridges). Zemley sources SCHOTT tubing and competes with it across the same vial and PFS product categories for pharmaceutical customers.
• Nipro Pharma Packaging: Nipro manufactures glass vials, prefilled syringes, and ampoules for the pharmaceutical industry, alongside rubber stoppers and related components. Directly competes with Zemley in glass PFS, vials, and cartridges for injectables.

Broad incumbents

• Becton Dickinson (BD) Pharmaceutical Systems: BD Pharmaceutical Systems manufactures prefilled syringes, auto-injectors, and drug delivery systems, including glass PFS. A large incumbent competing in Zemley's prefilled syringe segment for vaccine and biologic applications.
• West Pharmaceutical Services: West Pharmaceutical Services is a global leader in primary packaging components and integrated containment/delivery systems for injectable drugs, including elastomeric closures, syringes, and cartridge systems. Listed Zemley partner; broadly comparable across injectable primary packaging ecosystems.
• Datwyler (PHARMA & MEDICAL): Datwyler produces high-precision elastomer components for parenteral packaging and increasingly integrated container-closure systems. Listed Zemley partner; broadly comparable as a supplier of pharmaceutical primary packaging components adjacent to Zemley's glass offerings.

Emerging players

• Corning Pharmaceutical Technologies: Corning's pharmaceutical glass technologies (Valor, Corning Gorilla Glass-based vials) target pharmaceutical primary packaging with damage-resistant coatings. Adjacent/emerging competitor to traditional tubular glass vials including Zemley's portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.cn/injobs/company/74837260

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zemley Pharma Novotech ( Ningbo) Co.